GBA's "2021 Stock Phantasma"

“I am delighted to share this important milestone with our shareholders, as this round of financing comes at a key time for Slinger,” said Slinger CEO MikeBallardie.“We have aggressive growth plans and have successfully identified capital partners that are aligned with our vision. This financing strengthens our balance sheet while minimizing dilution, and provides us with the ability to execute quickly with our strategic plans. Additionally, these funds provide us with support for our planned uplisting, furthering our ability to build value for our shareholders. The oversubscription of our raise is a testament to the belief our investors have in the long term vision and capabilities of the Slinger team,”concluded Ballardie.
 
Low volume but it hurts- High Vol on the way up / low volume on the way down usually works out fine. I still think this is a $8+ stock Van...

Elys Game Technology, Corp. (ELYS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD

4.6400-0.2300 (-4.72%)
 
Roth Capital views Cellectar Biosciences as 'grossly undervalued' 11:26 CLRB

CLRB->
Cellectar Biosciences, Inc. (CLRB) Gummy Of the Day!
NasdaqCM - NasdaqCM Real Time Price. Currency in USD

0.9016+0.0344 (+3.97%)<---------
As of 11:48AM
 
Confluent, Inc. (CFLT) HOLDING UP CRAZY GOOD I THINK I SHOULD OF HELD ON HERE....
NasdaqGS - NasdaqGS Real Time Price. Currency in USD

52.71-1.29 (-2.40%)
As of 11:58AM EDT.
 
Back
Top